Treatment

Tackling Anemia in Chronic Kidney Disease

Anemia affects 15.4% of patients with chronic kidney disease (CKD) in the United States, with prevalence rising with disease progression, age, and among Black, Hispanic, and female populations....

CURATED BY: Stephen Thomas,
FNP-C, MSN, RN

Stephen Thomas,

FNP-C, MSN, RN
Nurse Practitioner, Nephrology Associates Medical Group

Fatigue and Sleep Quality as Mediators Between Depression and Renal Function in Patients With CKD-ND

Researchers aimed to investigate whether fatigue and poor sleep quality mediate the relationship between depression and renal function in patients...

Stephen Thomas,

FNP-C, MSN, RN
Nurse Practitioner, Nephrology Associates Medical Group

CURATED BY:
Stephen Thomas,
FNP-C, MSN, RN

Study Explores Immune Treatment for Skin Cancer in Kidney Transplant Patients

Kidney transplant recipients are at a heightened risk for developing skin cancers due to the long-term use of immunosuppressive drugs,...

Cristina Perez,

RN, MSN, FNP-C
Family Nurse Practitioner, Carelon Health

CURATED BY:
Cristina Perez,
RN, MSN, FNP-C

Gout and Chronic Kidney Disease: Prevalence, Challenges, and Treatment

Gout, a prevalent inflammatory arthritis, is triggered by monosodium urate (MSU) crystal deposits in joints due to elevated serum urate...

Cristina Perez,

RN, MSN, FNP-C
Family Nurse Practitioner, Carelon Health

CURATED BY:
Cristina Perez,
RN, MSN, FNP-C

Study Identifies Optimal eGFR for Dialysis Initiation in Advanced Chronic Kidney Disease

Researchers of this study aimed to determine the optimal estimated glomerular filtration rate (eGFR) for initiating dialysis in patients with...

Stephen Thomas,

FNP-C, MSN, RN
Nurse Practitioner, Nephrology Associates Medical Group

CURATED BY:
Stephen Thomas,
FNP-C, MSN, RN

New Technologies Offer Hope for Patients With End-Stage Renal Disease Amidst Donor Organ Shortage

Over two million people globally suffer from end-stage renal disease (ESRD), with kidney transplants being the best treatment option. However,...

Cristina Perez,

RN, MSN, FNP-C
Family Nurse Practitioner, Carelon Health

CURATED BY:
Cristina Perez,
RN, MSN, FNP-C

EMPA-KIDNEY Trial Shows Empagliflozin Reduces CKD Progression and Cardio Risks

The EMPA-KIDNEY trial evaluated empagliflozin's effectiveness in patients with chronic kidney disease (CKD) at various stages of progression. Participants with...